Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria

J Med Chem. 2021 Jul 22;64(14):9649-9676. doi: 10.1021/acs.jmedchem.1c00379. Epub 2021 Jul 13.

Abstract

Translocator protein 18 kDa [TSPO or peripheral-type benzodiazepine receptor (PBR)] was identified in the search of binding sites for benzodiazepine anxiolytic drugs in peripheral regions. In these areas, binding sites for TSPO ligands were recognized in steroid-producing tissues. TSPO plays an important role in many cellular functions, and its coding sequence is highly conserved across species. TSPO is located predominantly on the membrane of mitochondria and is overexpressed in several solid cancers. TSPO basal expression in the CNS is low, but it becomes high in neurodegenerative conditions. Thus, TSPO constitutes not only as an outstanding drug target but also as a valuable marker for the diagnosis of a number of diseases. The aim of the present article is to show the lesson we have learned from our activity in TSPO medicinal chemistry and in approaching the targeted delivery to mitochondria by means of TSPO ligands.

Publication types

  • Review

MeSH terms

  • Benzodiazepines / chemistry
  • Benzodiazepines / pharmacology*
  • Boron Compounds / metabolism*
  • Chemistry, Pharmaceutical
  • Humans
  • Ligands
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Molecular Structure
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / metabolism
  • Receptors, GABA / genetics
  • Receptors, GABA / metabolism*

Substances

  • Boron Compounds
  • Ligands
  • Receptors, GABA
  • TSPO protein, human
  • Benzodiazepines